Unpredictable ranks among foreign multinational drug corporations

Nobody easily predicts which foreign drug company will rank the top amid a confused feature of their business progress as shown by GSK and Sanofi-Synthelabo a sharp rise whereas by Pfizer Korea a slow own.

The top place having long occupied by Pfizer Korea was shift to GSK in 2005 at 0.93% sales plunge with 255,300 million won from 302,500 million won in 2004 (26% up). The sales drop of Pfiz...